In the past 10 years, there has been a lot of enthusiasm surrounding the use of serum
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …

Aims The Korean Association for the Study of the Liver (KASL) Practice Guidelines for
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

Background & Aims Information regarding long-term HBsAg kinetics during treatment with
nucleoside/nucleotide analogues is limited. The aim of the present study was to assess …

More than 360 million persons worldwide (6% of the world population) are chronically
infected by the hepatitis B virus (HBV). Although the incidence of HBV infection has …

Despite the availability of effective vaccines and antiviral therapy over the past two to three
decades, chronic hepatitis B virus (HBV) infection remains a major global health threat as a …

We previously demonstrated that pretreatment quantitative anti–hepatitis B core protein
(qAnti-HBc) levels can predict the treatment response for both interferon and nucleoside …

Background & Aims Few studies have investigated the effects of different nucleos (t) ide
analogues against hepatitis B virus (HBV) on levels of covalently closed circular DNA …

Using commercial quantitative assays, quantitative hepatitis B surface antigen (qHBsAg) has
improved our understanding and management of chronic hepatitis B (CHB). The HBsAg …